Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28632196
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28632196
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Int+J+Mol+Sci
2017 ; 18
(6
): ä Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches
#MMPMID28632196
de Las Vecillas Sánchez L
; Alenazy LA
; Garcia-Neuer M
; Castells MC
Int J Mol Sci
2017[Jun]; 18
(6
): ä PMID28632196
show ga
Drug hypersensitivity reactions (HSRs) are increasing in the 21st Century with
the ever expanding availability of new therapeutic agents. Patients with cancer,
chronic inflammatory diseases, cystic fibrosis, or diabetes can become allergic
to their first line therapy after repeated exposures or through cross reactivity
with environmental allergens. Avoidance of the offending allergenic drug may
impact disease management, quality of life, and life expectancy. Precision
medicine provides new tools for the understanding and management of
hypersensitivity reactions (HSRs), as well as a personalized treatment approach
for IgE (Immunoglobuline E) and non-IgE mediated HSRs with drug desensitization
(DS). DS induces a temporary hyporesponsive state by incremental escalation of
sub-optimal doses of the offending drug. In vitro models have shown evidence that
IgE desensitization is an antigen-specific process which blocks calcium flux,
impacts antigen/IgE/Fc?RI complex internalization and prevents the acute and late
phase reactions as well as mast cell mediator release. Through a "bench to
bedside" approach, in vitro desensitization models help elucidate the molecular
pathways involved in DS, providing new insights to improved desensitization
protocols for all patients. The aim of this review is to summarize up to date
information on the drug HSRs, the IgE mediated mechanisms of desensitization, and
their clinical applications.